Finance

Lists
RVU:WSE
Ryvu Therapeutics SA
PLN 18.00
+1.58%
(+0.28) 1D
Nov 13, 5:00:00 PM GMT+1  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for RVU...
Open
PLN 17.72
High
PLN 18.14
Low
PLN 17.62
Mkt. cap
416.16M
Avg. vol.
25.40K
Volume
15.67K
52-wk high
PLN 31.90
52-wk low
PLN 13.64
EPS
-PLN 2.94
Shares outstanding
23.12M
No. of employees
228
Open
PLN 17.72
High
PLN 18.14
Low
PLN 17.62
Mkt. cap
416.16M
Avg. vol.
25.40K
Volume
15.67K
52-wk high
PLN 31.90
52-wk low
PLN 13.64
EPS
-PLN 2.94
Shares outstanding
23.12M
No. of employees
228
News stories
From web sources and news partners
About Ryvu Therapeutics SA
CEO-
Employees228
Founded2007
Headquarters-
SectorHealth Care
Industry-
Websiteryvu.com
Next call in 6 days
Thu, Nov 19, 6:00 PM
Fiscal period
Q3 2026
- / -
Revenue / Est. (PLN)
- / 19.00M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Revenue
Net income
All values in PLN
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
19.50M
25.78M
21.71M
16.95M
Cost of goods sold
3.64M
4.08M
4.13M
3.52M
Cost of revenue
3.64M
4.08M
4.13M
3.52M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.29M
34.87M
26.59M
26.74M
Operating expense
41.28M
38.50M
29.99M
30.16M
Total operating expenses
44.92M
42.58M
34.12M
33.68M
Operating income
-25.42M
-16.80M
-12.41M
-16.73M
Other non operating income
1.54M
401.00K
2.11M
5.30M
EBT including unusual items
-24.71M
-17.52M
-12.47M
-12.90M
EBT excluding unusual items
-24.73M
-17.46M
-12.71M
-12.95M
Income tax expense
-
71.00K
180.00K
155.00K
Effective tax rate
-
-0.41%
-1.44%
-1.20%
Other operating expenses
1.44M
4.33M
1.11M
1.42M
Net income
-24.71M
-17.59M
-12.65M
-13.06M
Net profit margin
-126.73%
-68.22%
-58.25%
-77.02%
Earnings per share
-
-
-
-
Interest and investment income
1.28M
891.00K
558.00K
670.00K
Interest expense
-2.06M
-2.10M
-2.24M
-2.05M
Net interest expenses
-775.00K
-1.21M
-1.68M
-1.38M
Depreciation and amortization charges
2.86M
1.87M
2.15M
2.00M
EBITDA
-22.90M
-15.15M
-10.26M
-14.73M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps